Pathcision Medicine, Inc.
Watertown, MA
- UEI
- CK6QRF2GLBT1
- CAGE
- 9BD69
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 134 Coolidge Ave #2, Watertown, MA 02472, USA
- Website
- sophiatree.com
- Founded
- 2022
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$54,960 |
| FY2025 | $354,941 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir concept award for a novel delivery approach to transform metastatic pancreatic cancer treatment and prevention | National Cancer Institute (NIH) | $299,981 |
Quick answers
Is Pathcision Medicine, Inc. registered in SAM.gov?
Yes. Pathcision Medicine, Inc.'s SAM.gov registration is active through March 2, 2027.
How much has Pathcision Medicine, Inc. received in federal contracts?
Federal contracts obligated $354,941 to Pathcision Medicine, Inc. in fiscal year 2025 and $299,981 in fiscal years 2023 through 2027.
What is Pathcision Medicine, Inc.'s most recent federal award?
Pathcision Medicine, Inc.'s most recent federal contract award is Sbir concept award for a novel delivery approach to transform metastatic pancreatic cancer treatment and prevention (75N91025C00018), from National Cancer Institute (NIH), on August 11, 2025.
On GovTribe
See Pathcision Medicine, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors